Bioceres Crop Solutions Corp

Bioceres Crop Solutions Corp. engages in the provision of crop productivity solutions. The firm includes seeds, seed traits, seed treatments, biologicals, high-value adjuvants and fertilizers. It operates through the following segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment deals with the development and commercialization of integrated products that combine three complementary components biotechnological events, germplasm and seed treatments in order to increase crop productivity and create value for customers. The Crop Protection segment develops and produces adjuvants, insecticides and fungicides. The Crop Nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops and of fertilizers including bio fertilizers and micro granulated fertilizers that increases the productivity and yield of the crops. The company was founded on November 14, 2017 and is headquartered in Rosario, Argentina.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Bioceres Crop Solutions Reports Strong Q1 2023 Performance and Promising Growth Opportunities

BIOC's Q1 2023 showcased robust revenue and profit growth, driven by the crop nutrition segment and strategic partnerships. While weather conditions in Argentina posed challenges, the company's financial health improved significantly. The approval of HB4 grain importation in Brazil and progress in the Pro Farm front present promising opportunities for future growth.

Bioceres Crop Solutions Corp reports flat revenue, focuses on HB4 technology for growth

Bioceres Crop Solutions Corp faces challenges from severe drought impacting sales but shows strength in HB4 technology performance and revenue growth. The company aims for sales growth and profitability despite weather-related challenges. Opportunities lie in expanding HB4 technology globally and providing farmers with certainty in harvests.

Bioceres reports robust Q3 earnings, eyes growth through strategic partnerships

Bioceres Crop Solutions Corp delivered strong financial performance in Q3 2023, driven by revenue growth, improved profitability, and strategic partnerships.
While facing challenges from market disruptions and weather impacts, the company maintains a stable financial position and remains optimistic about future prospects.
With a focus on innovation, partnerships, and sustainability, Bioceres is well-positioned to capitalize on growth opportunities and navigate industry challenges effectively.

Bioceres Crop Solutions Corp achieves record revenues in Q4 2023

Bioceres Crop Solutions Corp delivered strong financial performance in Q4 2023, with record revenues, gross profit expansion, and increased adjusted EBITDA. The company faces challenges in flat revenues and inventory drawdown but is focused on higher margin products and strategic partnerships for growth. Opportunities exist in expanding product lines and partnerships for future revenue growth.

Bioceres Crop Solutions Corp reports strong Q1 earnings and global expansion opportunities

Bioceres Crop Solutions Corp's Q1 2024 performance reflects robust financial growth and strategic advancements in technology and market expansion.
While facing challenges in hedging and inventory valuation, the company is well-positioned to capitalize on opportunities in new markets and product offerings.
Overall, the company's optimistic outlook for fiscal '24, supported by strong financials and innovative initiatives, signals a promising path for growth and shareholder value.

Bioceres Crop Solutions Corp reports stellar Q2 results and eyes sustained growth amidst market challenges

Bioceres Crop Solutions Corp delivered robust financial performance in Q2 2024, driven by revenue growth, improved net income, and strong EBITDA. The company's focus on innovation, market execution, and technological advancements positions it well for sustained growth despite challenges in key markets.

Bioceres Crop Solutions reports Q3 revenue decline, eyes U.S. growth

Bioceres Crop Solutions Corp faced revenue declines in Q3 due to the Syngenta distribution agreement impact but saw growth in key segments. Despite challenges, the company remains optimistic about significant profitability improvement in Q4 and continued double-digit growth. Expansion plans in the U.S. market and new product launches in Brazil present growth opportunities.

Bioceres reports record revenue, eyes growth through innovation and profitability

Bioceres Crop Solutions Corp delivered strong financial performance amidst challenges, with a focus on profitability and innovation.
The company faces revenue-related challenges but is strategically positioned to capitalize on market opportunities and drive growth.
Management's emphasis on efficiency, profitability, and leveraging biological products signals a clear strategic direction for future success.

Bioceres reports revenue decline, focuses on innovation and profitability

Bioceres Crop Solutions Corp faced revenue challenges in Q1 2025 but demonstrated strength in key markets and innovation.
The company is strategically navigating challenges in product segments while focusing on profitability and operational efficiency.
Opportunities lie in driving growth through cash generation, market expansion, and maintaining a competitive edge in the industry.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Moolec Science SA

LUXEMBOURG / ACCESSWIRE / October 17, 2023 / Moolec Science SA (NASDAQ:MLEC; "Company"; "Moolec''), a science-based food ingredient company, announced today that it has entered into agreements to issue a convertible note due 2026 to Grupo Insud ("Insud") in a principal amount of approximately US $21 million (the "Insud Convertible Note") with a strike price of US $6.00 per share. The Insud Convertible Note will be issued against a cash payment of US $10 million and in-kind contributions to be made by Insud to Moolec.

Moolec Science Announces ~US $30 Million Capital Raise With Strategic Investors

LUXEMBOURG / ACCESSWIRE / October 17, 2023 / Moolec Science SA (NASDAQ: MLEC; "Company"; "Moolec''), a science-based food ingredient company, announced today that it has entered into agreements to issue a convertible note due 2026 to Grupo Insud ("Insud") in a principal amount of approximately US $21 million (the "Insud Convertible Note") with a strike price of US $6.00 per share. The Insud Convertible Note will be issued against a cash payment of US $10 million and in-kind contributions to be made by Insud to Moolec.

Moolec Science Announces Capital Raise With Strategic Investors for ~US $30 Million

Bioceres Crop Solutions Corp. (NASDAQ:BIOX ) Q4 2023 Earnings Conference Call September 11, 2023 4:30 PM ET Company Participants Paula Savanti - Head of Investor Relations Federico Trucco - Chief Executive Officer Enrique Lopez Lecube - Chief Financial Officer Conference Call Participants Ben Klieve - Wake Street Capital Market Kristen Owen - Oppenheimer Bobby Burleson - Canaccord Kemp Dolliver - Brookline Capital Markets Brian Wright - ROTH MKM Operator Good afternoon. Thank you for attending today's Bioceres Crop Solutions Fiscal Fourth Quarter and Full-Year 2023 Financial Results Conference Call.

Bioceres Crop Solutions Corp. (BIOX) Q4 2023 Earnings Call Transcript

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal fourth quarter and fiscal year ended June 30, 2023. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All.

Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full Year 2023 Financial and Operational Results

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Monday, September 11, 2023 at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter and fiscal year ended June 30, 2023. A press release detailing these results wil.

Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2023 Financial Results Conference Call on Monday, September 11, 2023 at 4:30 p.m. Eastern Time

Corteva Inc

GENEVA & ROSARIO, Argentina--(BUSINESS WIRE)--Corteva Agriscience (Corteva) (NYSE: CTVA) and Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), announced today that they have entered into an exclusive agreement to advance the availability of biological solutions in Europe. Under the agreement, Corteva Agriscience and Bioceres Crop Solutions will work jointly to accelerate the regulatory processes required to bring a cutting-edge bioinsecticide developed by Bioceres' subsidiary Pro Farm, t.

Corteva Agriscience and Bioceres Crop Solutions to Advance Availability of Biologicals in Europe

LUXEMBOURG / ACCESSWIRE / May 30, 2023 / Moolec Science SA (NASDAQ:MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, today reported its business update for the third quarter of Fiscal Year 2023 ended March 31, 2023. The main highlights of the Company's business update are as follows: On January 3, the Company started trading on Nasdaq under tickers "MLEC" for the common shares, and "MLECW" for the Company's warrants.

Moolec Science Presents Third Quarter FY 2023 Business Update

Bioceres Crop Solutions Corp. (NASDAQ:BIOX ) Q3 2023 Earnings Conference Call May 11, 2023 8:30 AM ET Company Participants Paula Savanti - Head, IR Federico Trucco - CEO Enrique Lecube - CFO Conference Call Participants Ben Klieve - Lake Street Capital Markets Brian Wright - ROTH MKM Bobby Burleson - Canaccord Kemp Dolliver - Brookline Capital Markets Kristen Owen - Oppenheimer Operator Hello and welcome today's Bioceres Crop Solutions Fiscal Third Quarter 2023 Financial Results Conference Call. My name is Bailey, and I'll be your operator today.

Bioceres Crop Solutions Corp. (BIOX) Q3 2023 Earnings Call Transcript

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal third quarter ended March 31, 2023. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in t.

Bioceres Crop Solutions Reports Fiscal Third Quarter 2023 Financial and Operational Results

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a fully integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, will hold a conference call on Thursday, May 11, 2023 at 8:30 a.m. Eastern Time to discuss its results for the third quarter ended March 31, 2023. A press release detailing these results will be issued prior to the call. Bioceres Chairman & Chief.

Bioceres Crop Solutions to Host Fiscal Third Quarter 2023 Financial Results Conference Call on Thursday, May 11, 2023 at 8:30 a.m. Eastern Time

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX), a fully integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, is pleased to announce the release of the company's inaugural FY22 Sustainability Report, entitled: Each Step We Take. The report is available for download here.

Bioceres Crop Solutions Releases FY22 Sustainability Report

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a fully integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, will participate in the 35th Annual Roth Conference scheduled for March 12-14, 2023 to be held at The Ritz Carlton Laguna Niguel in Dana Point, California.

Bioceres Crop Solutions to Participate in the 35th Annual Roth Conference

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a fully integrated global provider of crop productivity solutions designed to enable the transition of agriculture toward carbon neutrality, announced today that CTNBio, the National Biosafety Commission of Brazil´s Ministry of Science, Technology, and Innovation, has concluded the safety evaluation of HB4 Wheat, providing full approval for commercialization and cultivation in Brazil.

Bioceres Crop Solutions Announces Brazil´s Regulatory Approval of Drought Tolerant HB4® Wheat for Commercialization and Cultivation

Bioceres Crop Solutions Corp. (NASDAQ:BIOX ) Q2 2023 Earnings Conference Call February 9, 2023 8:30 AM ET Company Participants Paula Savanti - Head, Investor Relations Federico Trucco - Chief Executive Officer Enrique Lopez Lecube - Chief Financial Officer Conference Call Participants Ben Klieve - Lake Street Capital Markets Bobby Burleson - Canaccord Brian Wright - ROTH Capital Partners Kemp Dolliver - Brookline Capital Markets Operator Hello and welcome Bioceres Crop Solutions Fiscal Second Quarter 2023 Financial Results Conference Call. My name is Drew, and I'll be your operator today.

Bioceres Crop Solutions Corp. (BIOX) Q2 2023 Earnings Call Transcript

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a fully integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, announced financial results for the fiscal second quarter ended December 31, 2022. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards.

Bioceres Crop Solutions Reports Fiscal Second Quarter 2023 Financial and Operational Results

ROSARIO, Argentina--( BUSINESS WIRE )--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a fully integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, will hold a conference call on Thursday, February 9, 2023 at 8:30 a.m. Eastern Time to discuss its results for the second quarter ended December 31, 2022. A press release detailing these results will be issued prior to the call.

Bioceres Crop Solutions to Host Fiscal Second Quarter 2023 Financial Results Conference Call on Thursday, February 9, 2023 at 8:30 a.m. Eastern Time

Bioceres is a commercializer of inputs for agriculture and the licensee of patents for drought-resistant wheat and soy varieties. The company has a profitable segment financing its unprofitable growth segments.

Bioceres Is Expensive And Diluting Its Shareholders

Calyxt

– The merger will bring together the technology platforms and facilities of two pioneering companies to create a leader in precision gene editing focused on driving sustainable agriculture and the availability of renewable low-carbon ingredients – – Upon closure of the merger, Rory Riggs, Cibus Co-Founder, will become C hief Executive Officer and Chairman of the combined company and the Cibus leadership team will lead the new organization – ROSEVILLE, Minn. and SAN DIEGO , Jan. 17, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, and Cibus, a leader in precision gene editing in agriculture, today announced that both companies have entered into a definitive merger agreement under which Calyxt and Cibus will merge in an all-stock transaction.

Calyxt and Cibus Announce Definitive Merger Agreement to Create Industry-Leading Precision Gene Editing and Trait Licensing Company

S&W Seed

Trigall Genetics will own 80% of the newly created Australian company, Trigall Australia. Trigall Australia will develop and market high-performing wheat varieties for all Australian wheat production areas, leveraging S&W's existing commercial footprint, Bioceres Crop Solutions' technologies, and Florimond Deprez's breeding expertise.

S&W and Trigall Genetics Announce Agreement to Form Trigall Australia, a JV for Wheat Breeding in Australia

Braskem

Intrepid Potash

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.

Intrepid Potash, Braskem And More: Most Cheapest Stocks In The Materials Sector - Braskem (NYSE:BAK), Bioceres Crop Solutions (NASDAQ:BIOX)

Bioceres Crop Solutions Corp. (NASDAQ:BIOX ) Q1 2023 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Paula Savanti - Head of Investor Relations Federico Trucco - Chief Executive Officer Enrique Lopez Lecube - Chief Financial Officer Conference Call Participants Bobby Burleson - Canaccord Genuity LLC Benjamin Klieve - Lake Street Capital Markets, LLC Brian Wright - Roth Capital Partners Brian Dolliver - Brookline Capital Markets, LLC Steven Ralston - Zacks SCR Operator Good morning, good afternoon, and welcome to the Bioceres Crop Solutions Fiscal First Quarter 2023 Financial Results Conference Call. My name is Adam, and I'll be your operator today.

Bioceres Crop Solutions Corp. (BIOX) Q1 2023 Earnings Call Transcript

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a fully integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, announced financial results for the fiscal first quarter ended September 30, 2022.

Bioceres Crop Solutions Reports Fiscal First Quarter 2023 Financial and Operational Results

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a fully integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, will hold a conference call on Thursday, November 10, 2022 at 8:30 a.m.

Bioceres Crop Solutions to Host Fiscal First Quarter 2023 Financial Results Conference Call on Thursday, November 10, 2022 at 8:30 a.m. Eastern Time

BASEL, Switzerland & ROSARIO, Argentina--(BUSINESS WIRE)--Customers seeking cutting-edge biological seed treatment solutions will benefit from a global commercial and R&D collaboration announced today between Syngenta Crop Protection's Seedcare business and Bioceres Crop Solutions (NASDAQ: BIOX), a leader in biological crop productivity solutions. Bioceres is a key provider of biological inoculants, including rhizobia bacteria, which improve crop nutrition and support plant growth. This see

Syngenta Seedcare and Bioceres Crop Solutions collaborate to bring innovative biological seed treatments to market

Bioceres Crop Solutions Corp. (NASDAQ:BIOX ) Q4 2022 Earnings Conference Call September 8, 2022 8:30 AM ET Company Participants Paula Savanti - Head of Investor Relations Federico Trucco - Chief Executive Officer Enrique López Lecube - Chief Financial Officer Conference Call Participants Ben Klieve - Lake Street Capital Markets Kemp Dolliver - Brookline Capital Markets Dmitry Silversteyn - Water Tower Research Operator Hello and welcome to the Bioceres Crop Solutions Fiscal Fourth Quarter 2022 Financial Results Conference Call. My name is Alex.

News for Bioceres Crop Solutions Corp Stock (BIOX)